Clinical Trial: A Prospective, Multicenter, Phase II Clinical Study on the Treatment of Unresectable Advanced HCC with DEB-TACE Combined with SALOX-HAIC

U.S., Feb. 13 -- ClinicalTrials.gov registry received information related to the study (NCT06823050) titled 'A Prospective, Multicenter, Phase II Clinical Study on the Treatment of Unresectable Advanced HCC with DEB-TACE Combined with SALOX-HAIC' on Feb. 07.

Brief Summary: The aim of this study is to clarify the safety and efficacy of DEB-TACE combined with SALOX-HAIC in the treatment of unresectable advanced primary liver cancer. To determine whether this therapy can prolong the indicators such as PFS, TTP, OS, ORR, and DOR.

Study Start Date: March 01

Study Type: OBSERVATIONAL

Condition: Hepatocellular Carcinoma

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Xuhua Duan

Information provided by (Responsible Party): Xuhua Duan, The F...